Hemophilia Treatment Market by Type (Hemophilia A, Hemophilia B), Medicines (Octocogalfa, Nonacogalfa, Desmopressin) - Global Opportunity Analysis and Industry Forecast, 2021-2028
A00211 | Pages: NA | Jun 2021 | 7661 Views | | |
Author(s) : NA | Tables: NA | Charts: NA | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Hemophilia Treatment Market
Request Now !Hemophilia is a hereditary genetic disorder which impairs body’s ability to control coagulation or blood clotting. In this disease, clotting factors control bleeding from a broken vessel is deficient; therefore, coagulation does not occur. Of the two types of hemophilia, hemophilia A has higher prevalence compared to the other variant hemophilia B. . Acquired hemophilia is a rare non genetic form of hemophilia in which autoantibodies develop against the plasma coagulation factor. The development of novel coagulating factors and technological advancements are driving the growth of this market. Lack of available medicines, awareness of this disease and high cost of treatment are the major restraining factors in this market. The advancements in gene therapy and approaching approval of drugs for treatment of hemophilia provide growth opportunities in this market.
Global hemophilia treatment type market analysis
On the basis of type of hemophilia, this market can be classified into hemophilia A and hemophilia B. The market for hemophilia A is largest due to high prevalence rate of this variant of hemophilia.
Global hemophilia treatment medicine market analysis
On the basis of medicines used for treating hemophilia, this market is classified into octocogalfa, nonacogalfa, desmopressin and others. Many market players are focusing on gene therapy and there are many drugs in pipeline awaiting approval.
Hemophilia treatment geography market analysis
On the basis of geography, this market is classified into North America, Europe, Asia-Pacific and rest of the world (RoW). Presently, North America is the major contributor to the revenues generated in this market. Due to increasing medical tourism, Asia-Pacific region is expected to emerge as the largest market for hemophilia treatment market.
Competitive Landscape
The major market players contributing to this market are Bayer AG, Pfizer Inc., Baxter International Inc. Biogen Idec, Inc. and Swedish Orphan Biovitrum AB. The companies are focusing on approval of their drugs that are in the pipeline for treating hemophilia.
High level analysis
The report analyzes global hemophilia treatment market using Porter’s five forces model. Porter’s model explains the constitution of industry and helps in analyzing the bargaining power of buyers and suppliers. In this market, high initial capital investment may be a threat for new entrants.
Key Benefits
- This report gives a pin-point analysis of market dynamics. It analyzes the limitations in this market and also describes the growth opportunities.
- In this report estimations are made by considering present market conditions and future market potential for the period 2014-2020.
- The market for treatment of hemophilia is segmented based on the medicines used to give understanding about current scenario of available drugs and to understand the need for novel therapies
- The industrial scenario is analyzed using Porter’s five forces model, which will help in understanding the market and formulation of new strategies.
Key market Segments
The global hemophilia market is classified based on its types, medicines used and geography.
Market by Type
- Hemophilia A
- Hemophilia B
Market by Medicines
- Octocogalfa
- Nonacogalfa
- Desmopressin
- Others
Market by Geography
- North America
- Europe
- Asia-Pacific
- RoW
We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:
- Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
- Technologically sophisticated and reliable insights through well audited and veracious research methodology
- Sovereign research proceeds that present a tangible depiction of marketplace
With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.
Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, web-casts and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast
Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develops analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth and forecasts
Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:
- Chief executives and VPs of leading corporations specific to industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)
Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
REQUEST TOC/SAMPLE
Purchase Full Report of
Hemophilia Treatment Market- Global Opportunity Analysis and Industry Forecast, 2021-2028
- Online Only
-
$3,456$3,110 - Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Data Pack
-
$3,840$3,456 - Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Single User
-
$5,769$5,192 - Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Five Users
-
$6,450$5,805 - Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
-
Enterprise
License/PDF -
$8,995$8,096 - Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
10%
Discount
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Featured Reports
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers